OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Pascale BouillÃ©, PHD, CEO of Flash Therapeutics, was initially involved in fundamental research in retrovirology and has worked in a number of government and biotechnology research laboratories before creating Vectalys in 2005. She has built up over 15 years' experience in R&D projects in the fields of drug discovery and virology. BouillÃ© has conducted gene therapy trials for the Genethon laboratories with Dr. Olivier Danos and implemented the transition of viral vector tools from a technology-based to a commercially oriented product with Vectalys.
The changing regulatory and manufacturing environment is ushering in a new approach to drug development.